When did Royalty Pharma report Q4 2024 earnings?

Royalty Pharma (RPRX) reported Q4 2024 earnings on February 11, 2025 before market open.

What were Royalty Pharma's Q4 2024 revenue and EPS?

Royalty Pharma reported revenue of $594.0M and diluted EPS of $1.15 for Q4 2024.

Did Royalty Pharma beat estimates in Q4 2024?

Revenue missed the consensus estimate of $687.1M by $93.1M. EPS beat the consensus estimate of $0.99 by $0.16.

Where can I find Royalty Pharma's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001802768-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.

Royalty Pharma RPRX Q4 2024 Annual earnings

Reported February 11, 2025 · Before market open

Revenue$594.0MMiss by $93.1M Diluted EPS$1.15Beat by $0.16

Revenue estimate$687.1M

EPS estimate$0.99

Next report

Aug 5, 2026 (In 3 weeks)

Revenue estimate$789.5M

EPS estimate$1.27

Financials

Q4 2024

Income statement

See full

Revenue$593.6M-0.4%

Operating income$361.5M-41.0%

Net income$208.2M-57.9%

EPS (diluted)$0.47-57.3%

Balance sheet

See full

Cash & equivalents$929.0M+94.8%

Total debt$7.6B+24.1%

Total equity$10.3B+2.6%

Total assets$18.2B+11.2%

Cash flow

See full

Operating cash flow$742.5M-3.9%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$11.33B-9.7%

Enterprise value$18.02B-1.0%

P/E13.2×+2.1×

P/S5×-0.3×

Profitability

See full

Operating margin57.1%-6.3pp

Net margin37.9%-10.2pp

Returns & leverage

See full

Return on equity8.4%-3.2pp

Debt / equity0.7×+0.1×

Current ratio1.4×-6.5×

Versus estimates

Revenue

Q1 2026$925.0MBeat by $43.3M Q4 2025$874.0MBeat by $67.0M Q3 2025$609.3MMiss by $108.1M Q2 2025$578.7MMiss by $94.3M Q1 2025$568.2MMiss by $137.1M

Q4 2024$594.0MMiss by $93.1M

Diluted EPS

Q1 2026$1.30Beat by $0.08 Q4 2025$1.46Beat by $0.17 Q3 2025$1.17Beat by $0.18 Q2 2025$1.14Beat by $0.11 Q1 2025$1.06Beat by $0.11

Q4 2024$1.15Beat by $0.16

Ask the moment Royalty Pharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Royalty Pharma report Q4 2024 earnings?: Royalty Pharma (RPRX) reported Q4 2024 earnings on February 11, 2025 before market open.
What were Royalty Pharma's Q4 2024 revenue and EPS?: Royalty Pharma reported revenue of $594.0M and diluted EPS of $1.15 for Q4 2024.
Did Royalty Pharma beat estimates in Q4 2024?: Revenue missed the consensus estimate of $687.1M by $93.1M. EPS beat the consensus estimate of $0.99 by $0.16.
Where can I find Royalty Pharma's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001802768-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.